February 2026

Importance of diagnostic testing in the management of Antimicrobial Resistance (AMR). 

Importance of diagnostic testing in the management of Antimicrobial Resistance (AMR).  Feb 23 2026  Australia’s CDC has just published the Aura Report, the sixth Australian report on antimicrobial use and resistance in human health.  Here is a link to the full report.  AURA REPORT – Sixth Australian report on antimicrobial use and resistance in human health  In […]

Importance of diagnostic testing in the management of Antimicrobial Resistance (AMR).  Read More »

Same root cause, different impact – HTA PBAC and MSAC have passed their use by date 

Same root cause, different impact – HTA PBAC and MSAC have passed their use by date  10th February 2026  This week the ABC reported on the lack of PBS funding for some commonly used medicines. See the link below for the full article.   Essentially the issue boils down to the same root cause as we find for

Same root cause, different impact – HTA PBAC and MSAC have passed their use by date  Read More »

PTA CEO Calls for Urgent Healthcare Reform as Policy Reviews Stall 

  Dean Whiting warns Australia has a narrow window to implement systemic change before healthcare becomes unsustainable  January 2025 – Pathology Technology Australia (PTA) CEO Dean Whiting has delivered a sobering assessment of the healthcare sector’s trajectory, warning that critical policy initiatives have stalled despite the government’s return to office earlier this year.  Speaking with Health

PTA CEO Calls for Urgent Healthcare Reform as Policy Reviews Stall  Read More »

Scroll to Top